The company’s total revenue also increased 4.1 percent, from $48.5 million in the third quarter of 2012 to $50.4 million. However, 2013’s third quarter net loss came in at $2.6 million, up from 2012’s $1.3 million.
Alphatec has several devices lined up for this year, including the Pegasus anchored, anterior cervical interbody device; Alphatec Solus anterior lumbar interbody fusion device; and ILLICO Multilevel minimally invasive system.
More Articles on Devices:
Integra LifeSciences Launches Hollywood VI Lumbar Fusion Cage
Medtronic Spine Launches Device for Multilevel Spinal Fusion
Wenzel Spine Launches Cervical Interbody Fusion Implant
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
